Papers
22
Total Citations
744
H-Index
11
About
Taiyuan Li is a prominent surgical oncologist whose research has fundamentally advanced the understanding of robotic-assisted minimally invasive surgery for colorectal and gastric cancers. His work centers on comparing robotic, laparoscopic, and open surgical approaches, with a particular focus on rectal cancer outcomes, oncological efficacy, and patient quality of life. Li's most celebrated contribution is the REAL trial — a landmark multicentre randomised controlled trial comparing robotic versus laparoscopic surgery for middle and low rectal cancer — which has garnered over 453 citations since its 2022 publication, making it among the most influential studies in colorectal surgical oncology. His subsequent 2025 follow-up examining 3-year locoregional recurrence rates further demonstrates his commitment to rigorous long-term outcomes research. Beyond rectal cancer, Li has investigated robotic left colectomy, gastric cancer surgery, and urogenital function preservation following total mesorectal excision, reflecting his broad surgical expertise. His analyses of robotic surgery learning curves and nationwide adoption patterns in China have provided critical guidance for surgeons transitioning to robotic platforms. Collectively, Li's body of work — spanning prospective trials, cohort studies, and retrospective analyses — has helped establish evidence-based frameworks for robotic colorectal surgery adoption globally, cementing his reputation as a leading voice in minimally invasive oncological surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer79 citations · 2025
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10